Article
PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort.
Journal of neuro-oncology - 1 Aug 2023
Otani Ryohei, Ikegami Masachika, Yamada Ryoji, Yajima Hirohisa, Kawamura Shinji, Shimizu Sakura, Tanaka Shota, Takayanagi Shunsaku, Takami Hirokazu, Yamaguchi Tatsuro
Abstract excerpt
PURPOSE: Glioblastoma (GBM) is the most common type of primary malignant brain tumor and has a poor prognosis. Identifying novel targets and stratification strategies is urgently needed to improve patient survival. The present study aimed to identify clinically relevant genomic alterations in IDH-wildtype GBM using data from comprehensive genomic profiling (CGP) assays performed nationwide in Japan. METHODS: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
